COMPARING OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION OF NATIVE ARTERY VERSUS BYPASS GRAFT IN PATIENTS WITH PRIOR CORONARY ARTERY BYPASS GRAFTING : A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/5nzdqh66Keywords:
Percutaneous coronary intervention, native artery, bypass graft, prior coronary artery bypass graftingAbstract
Background: Percutaneous coronary intervention (PCI) is common in patients with prior coronary artery bypass graft surgery (CABG), however the data on the association between the PCI target-vessel and clinical outcomes are not clear. We aimed to investigate long-term clinical outcomes of patients with prior CABG who underwent PCI of either bypass graft or native artery. We performed a systematic review of observational studies comparing PCI of either bypass graft or native artery in patients with prior CABG.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2013 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 23 articles, whereas the results of our search on SagePub brought up 19 articles. The results of the search conducted for the last year of 2013 yielded a total 9 articles for PubMed and 5 articles for SagePub. In the end, we compiled a total of 5 papers, 4 of which came from PubMed and 1 of which came from SagePub. We included five research that met the criteria.
Conclusion: Most PCIs performed in prior CABG patients are done in native coronary artery lesions. Compared with native coronary PCI, bypass graft PCI is independently associated with higher in-hospital mortality.
References
. Ma X, Dong R, Chen P, Zhao Y, Zeng C, Xin M, et al. Percutaneous coronary intervention in diabetic versus non-diabetic patients with prior coronary artery bypass grafting: a propensity score matching study. BMC Cardiovasc Disord [Internet]. 2020 [cited 2023 Nov 4];159. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137249/
. Farag M, Brilakis ES, Gasparini GL, Spratt JC, Egred M. Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients with Prior Coronary Artery Bypass Graft Surgery. Vol. 23, Reviews in Cardiovascular Medicine. IMR Press Limited; 2022.
. Brilakis ES, O’donnell CI, Penny W, Armstrong EJ, Tsai T, Maddox TM, et al. Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. 2016.
. Abdelrahman A, Debski M, More R, Abdelaziz HK, Choudhury T, Eichhofer J, et al. One-year outcomes of percutaneous coronary intervention in native coronary arteries versus saphenous vein grafts in patients with prior coronary artery bypass graft surgery. Cardiol J [Internet]. 2022 [cited 2023 Nov 4];29(3):396–404. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170321/
. Pokala NR, Menon RV, Patel SM. Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesions. Catheter Cardiovasc Interv. 2015;
. Budassi S, Zivelonghi C, Dens J, Bagnall AJ, Knaapen P, Avran A, et al. Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGium, and UnitEd Kingdom (RECHARGE). Catheter Cardiovasc Interv [Internet]. 2021 Jan 1 [cited 2023 Nov 4];97(1):51–60. Available from: https://pubmed.ncbi.nlm.nih.gov/32369681/
. Nikolakopoulos I, Choi JW, Khatri JJ, Alaswad K, Doing AH, Dattilo P, et al. Follow-up Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With and Without Prior Coronary Artery Bypass Graft Surgery: Insights From the PROGRESS-CTO Registry. J Invasive Cardiol [Internet]. 2020 [cited 2023 Nov 4];32(8):315–20. Available from: https://pubmed.ncbi.nlm.nih.gov/32428867/
. Hernandez-Suarez DF, Azzalini L, Moroni F, de Paula JET. Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients with Prior Coronary Artery Bypass Graft Surgery: Insights from the LATAM CTO Registry. Catheter Cardiovasc Interv [Internet]. 2022 [cited 2023 Nov 4];99(2):245–53. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885848/
. Shoaib A, Mohamed M, Curzen N, Ludman P, Zaman A, Rashid M, et al. Clinical outcomes of percutaneous coronary intervention for chronic total occlusion in prior coronary artery bypass grafting patients. Catheter Cardiovasc Interv [Internet]. 2022 [cited 2023 Nov 4];99(1):74–84. Available from:
https://pubmed.ncbi.nlm.nih.gov/33942465/
. Toma A, Stahli BE, Gick M, Colmsee H, Gebhard C, Mashayekhi K, et al. Long-Term Follow-Up of Patients With Previous Coronary Artery Bypass Grafting Undergoing Percutaneous Coronary Intervention for Chronic Total Occlusion. Am J Cardiol [Internet]. 2016 [cited 2023 Nov 4];118(11):1641–6. Available from: https://pubmed.ncbi.nlm.nih.gov/27692593/
. Lee MS, Park SJ, Kandzari DE, Kirtane AJ. Saphenous Vein Graft Intervention. JACC Journals. 2013;4(8):831–43.
. Abdel-karim AR, Silva MD, Lichtenwalter C, de Lemos JA, Obel O, Addo T. Prevalence and outcomes of intermediate saphenous vein graft lesions: Findings from the stenting of saphenous vein grafts randomized-controlled trial. International Journey of Cardiology [Internet]. 2013 [cited 2023 Nov 4];2468–73. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0167527313004245
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
